title: Further characterization of proteolytic Clostridium botulinum type A5 reveals that neurotoxin formation is unaffected by loss of the cntR (botR) promoter sigma factor binding site.
authors.forename: Andrew T
authors.initials: AT
authors.lastname: Carter
authors.forename: David R
authors.initials: DR
authors.lastname: Mason
authors.forename: Kathie A
authors.initials: KA
authors.lastname: Grant
authors.forename: Giovanna
authors.initials: G
authors.lastname: Franciosa
authors.forename: Paulo
authors.initials: P
authors.lastname: Aureli
authors.forename: Michael W
authors.initials: MW
authors.lastname: Peck
mesh_terms: D001426:Bacterial Proteins / Q000235:genetics*; D001665:Binding Sites; D003014:Clostridium botulinum / Q000378:metabolism*; D015169:Colony Count, Microbial; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D023061:Gene Order; D005798:Genes, Bacterial; D050296:Microbial Viability; D008969:Molecular Sequence Data; D009498:Neurotoxins / Q000096:biosynthesis*; D011401:Promoter Regions, Genetic; D017422:Sequence Analysis, DNA; D017384:Sequence Deletion; D012808:Sigma Factor / Q000378:metabolism*; D015534:Trans-Activators / Q000235:genetics*
chemical_list: D001426:Bacterial Proteins; C116103:BotR protein, Clostridium botulinum; D004269:DNA, Bacterial; D009498:Neurotoxins; D012808:Sigma Factor; D015534:Trans-Activators